Abstract
Since antithrombin III (AT III) substitution to normal activities could not be shown to have major beneficial effects in patients with end-stage chronic liver disease in a variety of clinical settings, we tested the hypothesis that substitution to supranormal activities decreases systemic procoagulant turnover better in this patient group. Controlled prospective clinical study. Operating rooms at a University Hospital. Twenty-four patients with histologically verified liver cirrhosis consecutively scheduled for liver transplantation. Nineteen patients were given an antithrombin III concentrate to achieve either 100% (n = 10) or 175% (n = 9) AT III activity. Control patients (n = 5) received saline 0.9% instead. Molecular markers of coagulation activation, platelet count and aggregability, and global coagulation variables were measured prior to AT III infusion and 60 min thereafter. In both AT III-treated groups thrombin-antithrombin III-complex increased significantly (p < 0.005), whereas prothrombin fragment F1 + 2, soluble fibrin and D-dimer concentrations, as well as other variables, did not show major changes. Despite thrombin inhibition by AT III in patients with end-stage chronic liver disease, systemic procoagulant turno...Continue Reading
References
Apr 22, 1978·Lancet·H G SchipperJ W ten Cate
Jun 1, 1978·European Journal of Clinical Investigation·D CollenM Verstraete
Jun 1, 1978·Thrombosis Research·L H KahléJ W ten Cate
Jan 1, 1977·Seminars in Thrombosis and Hemostasis·K LechnerE Thaler
Jul 1, 1975·Annals of Internal Medicine·M ColemanM Pasmantier
Dec 1, 1992·Thrombosis Research·F BaudoL Belli
May 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·F J Walker, P J Fay
Jan 1, 1991·Haemostasis·G PalaretiS Coccheri
Jan 1, 1989·Seminars in Thrombosis and Hemostasis·G Müller-Berghaus
Oct 1, 1987·Seminars in Thrombosis and Hemostasis·J A Marcum, R D Rosenberg
May 15, 1986·The New England Journal of Medicine·L H Clouse, P C Comp
Aug 1, 1988·Gut·K FujiwaraH Oka
Jan 1, 1974·Annual Review of Medicine·M VerstraeteD Collen
Aug 1, 1971·The Journal of Clinical Investigation·G N TytgatM Verstraete
Apr 10, 1984·Biochemistry·J A Marcum, R D Rosenberg
May 1, 1984·Journal of Clinical Pathology·E KnotG N Tytgat
Sep 1, 1982·British Journal of Haematology·H G Schipper, J W ten Cate
Apr 15, 1994·Thrombosis Research·M ShimadaK Sugimachi
Mar 1, 1993·Journal of Hepatology·P G LangleyR Williams
Jan 1, 1993·Seminars in Thrombosis and Hemostasis·R U SchererW J Kox
Feb 1, 1964·The Journal of protozoology·S A RAHMANW J TYZNIK
Citations
Oct 30, 2009·Annals of Surgery·Hirofumi KawanakaYoshihiko Maehara
Jul 5, 2005·Critical Care Clinics·Jody L Kujovich
May 15, 2001·European Journal of Anaesthesiology·Y OzierP De Moerloose
Sep 27, 2014·Journal of the American College of Surgeons·Hirofumi KawanakaYoshihiko Maehara
Jan 5, 2001·Baillière's Best Practice & Research. Clinical Gastroenterology·P A McCormick, K M Murphy
Oct 16, 1999·The American Journal of Gastroenterology·J H Joist
Feb 1, 2005·World Journal of Gastroenterology : WJG·Sasa-Marcel MaksanJan Schmidt
Feb 10, 2016·The Cochrane Database of Systematic Reviews·Mikkel AllingstrupArash Afshari
Jul 13, 2006·International Anesthesiology Clinics·Theo H N Groenland, Robert J Porte
Oct 3, 2006·Current Opinion in Anaesthesiology·R U Scherer, S Pulletz